Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).

@article{Hoppe2011HeparinOA,
  title={Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).},
  author={Berthold Hoppe and G J Burmester and Thomas Doerner},
  journal={Current opinion in rheumatology},
  year={2011},
  volume={23 3},
  pages={299-304}
}
PURPOSE OF REVIEW Presence of antiphospholipid antibodies (aPL) is associated with unsuccessful pregnancy outcome. Based on an early concept of aPL-induced thrombophilia and placental thrombosis, antithrombotic interventions have been used to reduce incidence of miscarriage in antiphospholipid antibody syndrome (APS). The aim of this review is to summarize current knowledge on pathogenesis of miscarriage in APS and the impact of different antithrombotic therapy strategies. RECENT FINDINGS… CONTINUE READING
9 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Decreased expression of heparinbinding epidermal growth factorlike growth factor as a newly identified pathogenic mechanism of antiphospholipidmediated defective placentation

  • N DiSimone, R Marana, R Castellani
  • Arthritis Rheum
  • 2010

Low molecular weight heparin and aspirin for recurrent pregnancy loss : results from the randomized , controlled HepASA Trial

  • CA Laskin, KA Spitzer
  • J Rheumatol
  • 2009

Similar Papers

Loading similar papers…